Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Aug 02, 2023 02:29PM

Aug 03, 2023 11:06AM

Aug 03, 2023 11:47AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New SEDAR page

in response to

New SEDAR page

jonzobot

posted on Aug 06, 2023 07:54AM

We have not seen Zenith's 4th quarter and annual audited financials of April 31, 2023, and MD&A. They have had the available capital from Exempt Distributions as reported in these past months to get it done on time if that is the main reason.

Koo

1 Recommendations

Re: New SEDAR page

fuzzyjr

Aug 08, 2023 12:41PM

Re: New SEDAR page

fuzzyjr

Aug 08, 2023 04:16PM

Re: New SEDAR page

KOO-KOO2

Aug 10, 2023 08:15AM

Re: New SEDAR page